MB, Levis & Associates’s Oracle ORCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ORCL
FWIA
MB, Levis & Associates's ORCL Position: Q2 2026 in Review
MB, Levis & Associates increased its Oracle (ORCL) stake by 0.28% in Q2 2026, buying an estimated $181 and bringing the position to 358 shares worth $52.5K. The position accounts for 0.02% of the portfolio, ranked #104.
MB, Levis & Associates first reported a position in ORCL in Q4 2022 and has held it in 15 quarters since. The position peaked at $100K in Q3 2025. 1,577 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.
- MB, Levis & Associates held 358 shares of Oracle worth $52.5K as of Q2 2026.
- MB, Levis & Associates bought 1 Oracle share in Q2 2026, an estimated $181.
- Oracle made up 0.02% of MB, Levis & Associates's portfolio in Q2 2026, its #104 holding.
- MB, Levis & Associates first reported a position in Oracle in Q4 2022 and has held it in 15 quarters since.
- MB, Levis & Associates's Oracle position peaked at $100K in Q3 2025.
- 1,577 funds tracked by Wall St. Rank held Oracle as of Q2 2026.
Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.